# A Study of Vascular Endothelial Growth Factor (VEGF) Inhibition in Patients With Unilateral Upper Extremity Lymphedema Following Treatment for Cancer

> **NCT00827372** · PHASE2 · COMPLETED · sponsor: **Kathy Miller** · enrollment: 10 (actual)

## Conditions studied

- Lymphedema

## Interventions

- **DRUG:** Pazopanib

## Key facts

- **NCT ID:** NCT00827372
- **Lead sponsor:** Kathy Miller
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00827372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00827372, "A Study of Vascular Endothelial Growth Factor (VEGF) Inhibition in Patients With Unilateral Upper Extremity Lymphedema Following Treatment for Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00827372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*